Search results for "Oxide"

showing 10 items of 6424 documents

Clopidogrel and aspirin in the prevention of thromboembolic complications after mechanical aortic valve replacement (CAPTA)

2003

Axel Schlitt*, Ralf S. von Bardeleben, Anne Ehrlich, Antje Eimermacher, Dirk Peetz, Manfred Dahm, Hans J. Rupprecht Department of Medicine II, Johannes Gutenberg-University Mainz, Langenbeckstr. 1, 55131 Mainz, Germany Coordination Center for Clinical Studies, Johannes Gutenberg-University Mainz, Mainz, Germany Clinic for Clinical Chemistry and Laboratory Medicine, Johannes Gutenberg-University Mainz, Mainz, Germany Department of Cardiothoracic and Vascular Surgery, Johannes Gutenberg-University Mainz, Mainz, Germany

AdultMalemedicine.medical_specialtyTiclopidineTreatment outcomeAdministration OralHemorrhagePilot ProjectsValvula aorticaProstaglandin-Endoperoxide SynthaseThromboembolismmedicineHumansOral anticoagulationAgedAspirinAspirinbusiness.industryHematologyMiddle AgedClopidogrelClopidogrelSurgeryTreatment OutcomeAortic ValveHeart Valve ProsthesisAortic valve surgeryPhenprocoumonDrug Therapy CombinationFemalebusinessVenous diseasemedicine.drugThrombosis Research
researchProduct

Oxidative stress in young subjects with acute myocardial infarction: evaluation at the initial stage and after 12 months.

2007

In 105 subjects (97 men and 8 women) aged <46 years (mean age 39.6 ± 5.5 years), with recent acute myocardial infarction (T1), thiobarbituric acid reactive substances and total antioxidant status were determined; NO production was evaluated by measuring the nitrite and nitrate (NOx) concentration. The patients with acute myocardial infarction were subdivided according to the main risk factors, number of risk factors, and extent of coronary lesions. The evaluation was repeated after 12 months (T2). In these subjects, thiobarbituric acid reactive substances and NOx were significantly increased and total antioxidant status was significantly decreased at T1. In single risk factor, only NO m…

AdultMalemedicine.medical_specialtyTime FactorsThiobarbituric acidMyocardial Infarctionmedicine.disease_causeNitric OxideGastroenterologyNitric oxideLipid peroxidationchemistry.chemical_compoundRisk FactorsInternal medicineMedicineHumansMyocardial infarctionStage (cooking)Risk factorNitritebusiness.industryacute myocardial infarction in young peopleHematologyGeneral Medicineoxidative statuMiddle Agedmedicine.diseaseSurgeryOxidative StresschemistryAcute DiseaseFemaleLipid PeroxidationbusinessOxidative stressClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
researchProduct

Pulmonary embolism location is associated with the co-existence of the deep venous thrombosis.

2019

Multiple studies have shown that in approximately half of individuals with pulmonary embolism (PE), the deep venous thrombosis (DVT) is not evident at the moment of PE diagnosis. The underlying factors and the origin of PE in these patients are not completely understood: missed DVT, embolization of DVT in its entirety, or de-novo PE being possible explanations. The aim of this study was to evaluate the differences in PE patient with or without co-existing DVT. Sixty-three consecutive PE patients were included. Whole leg bilateral Doppler compression ultrasound was performed to all patients. The PE location and extension, C-reactive protein, platelet count, hemostatic markers FV, FVIII, FXII…

AdultMalemedicine.medical_specialtyVEIN THROMBOSISmedicine.medical_treatment030204 cardiovascular system & hematologyFibrinogenPulmonary function testing03 medical and health sciencesTHROMBOEMBOLISM0302 clinical medicineInternal medicineSCOREmedicineFactor V LeidenFACTOR-V-LEIDENHumanscardiovascular diseasesEmbolizationProspective Studiescoagulationhemostatic markersProspective cohort studydeep venous thrombosisAgedRISKVenous ThrombosisHemostasisLegbusiness.industryUltrasonography DopplerHematologyGeneral MedicineNITRIC-OXIDE MEASUREMENTSMiddle Agedmedicine.disease3. Good healthPulmonary embolismVenous thrombosis3121 General medicine internal medicine and other clinical medicineHemostasisisolated pulmonary embolismCardiologyFemalebusinessPulmonary Embolism030215 immunologymedicine.drugBlood coagulationfibrinolysis : an international journal in haemostasis and thrombosis
researchProduct

Alveolar nitric oxide and asthma control in mild untreated asthma

2012

Background The role of the peripheral airways in asthma is increasingly being recognized as a potential target for the achievement of optimal control of the disease. We postulated that the inflammatory changes of the small airways are implicated in the lack of asthma control in mild asthma. Objective To test this hypothesis, we measured the alveolar fraction of exhaled NO (C alv NO) in patients with mild asthma with different levels of control of symptoms. Methods Seventy-eight patients with asthma (35 men, age, 37 ± 15 years; FEV 1 percentage of predicted, 100% ± 9%) were studied. Asthma control was assessed by using the Asthma Control Test (ACT). Measurements of exhaled NO at multiple con…

AdultMalemedicine.medical_specialtyVital capacityImmunologySettore MED/10 - Malattie Dell'Apparato RespiratorioNitric OxideGastroenterologyNitric oxideYoung Adultchemistry.chemical_compoundFEV1/FVC ratioAsthma controlInternal medicinemedicineHumansImmunology and AllergyYoung adultAsthmabusiness.industryExhalationmedicine.diseaseAsthmaRespiratory Function Testsrespiratory tract diseaseschemistryExhalationAnesthesiaFemalebusinessAsthma Control TestJournal of Allergy and Clinical Immunology
researchProduct

Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health.

2003

Oxidation of low-density lipoprotein (LDL) and hyperhomocysteinemia are believed to play a role in therogenesis. Whether n-3 polyunsaturated fatty acids increase LDL susceptibility to oxidation or influence homocysteine (Hcy) metabolism has long been a subject of controversy. In this study, we evaluated the effect of 8 weeks of dietary supplementation with 6 g/day of fish oil (FO; 3 g of n-3 fatty acids) on plasma lipoproteins, in vitro LDL peroxidation, antioxidant status, and plasma Hcy concentrations in 16 normolipidemic subjects. FO rapidly and significantly (P < .01) decreased plasma total and very low density lipoprotein triglyceride concentrations and had no effect on LDL or high-den…

AdultMalemedicine.medical_specialtyalpha-TocopherolNitric OxideThiobarbituric Acid Reactive SubstancesPathology and Forensic Medicinechemistry.chemical_compoundHigh-density lipoproteinFish OilsDietary Fats UnsaturatedInternal medicineFatty Acids Omega-3medicineHumansHomocysteineNitritesTriglycerideschemistry.chemical_classificationNitratesTriglycerideCholesterolCholesterol HDLGeneral MedicineCholesterol LDLMiddle Agedbeta CaroteneEicosapentaenoic acidGlutathioneLipoproteins LDLEndocrinologychemistryBiochemistryDocosahexaenoic acidLow-density lipoproteinFemaleLipid PeroxidationCopperPolyunsaturated fatty acidLipoproteinThe Journal of laboratory and clinical medicine
researchProduct

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients.

2002

Cardiovascular manifestations are frequent findings in patients with thyroid hormone disorders. Nitric oxide (NO) plays a key role in vascular, endothelial-mediated relaxation. NO is synthesized from L-arginine by NO synthase, an enzyme inhibited by endogenous compounds, mainly asymmetric dimethylarginine [asymmetric N(G),N(G)-dimethyl-L-arginine (ADMA)]. The aim of our work was to investigate whether plasma L-arginine and dimethylarginine concentrations and NO production are altered in hypo- and hyperthyroid patients, compared with control subjects. L-arginine, ADMA and symmetric dimethylarginine were analyzed by HPLC. NO was measured as plasma nitrite plus nitrate (NO(x)) concentration by…

AdultMalemedicine.medical_specialtyendocrine system diseasesEndotheliumEndocrinology Diabetes and MetabolismClinical BiochemistryArginineNitric OxideBiochemistryHyperthyroidismNitric oxidechemistry.chemical_compoundEndocrinologyHypothyroidismGriess testReference ValuesInternal medicineBlood plasmamedicineHumansNitriteNitritesAgedNitratesbiologyBiochemistry (medical)Osmolar ConcentrationMiddle AgedNitric oxide synthaseEndocrinologymedicine.anatomical_structurechemistrybiology.proteinFemaleNitric Oxide SynthaseAsymmetric dimethylarginineHormoneThe Journal of clinical endocrinology and metabolism
researchProduct

Alfa-lipoic acid and superoxide dismutase in the management of chronic neck pain: a prospective randomized study

2014

Background and Objective Since oxidative stress plays a pathogenetic role in chronic neck pain (CNP), we investigated whether a combination of α-lipoic acid (ALA) and superoxide dismutase (SOD) might improve pain control and the efficacy of physiotherapy (“multimodal therapy”) in patients with CNP. Setting This study was conducted in the Rehabilitation Unit of the Department of Surgical and Oncological Sciences at the University Policlinic in Palermo, Italy. Design and Patients This was a prospective, randomized, open study in outpatients. Intervention Patients randomly received either physiotherapy alone (group 2; n = 45) or a combination of ALA 600 mg and SOD 140 IU daily in addition to p…

AdultMalemedicine.medical_specialtyperipheral neuropathyVisual Analog Scalemedicine.disease_causeBioinformaticsGastroenterologyalfa-lipoic acidSuperoxide dismutasechemistry.chemical_compoundInternal medicinemedicineHumansOriginal Research ArticleProspective StudiesProspective cohort studyPhysical Therapy ModalitiesAgedAged 80 and overPharmacologyNeck painNeck PainThioctic Acidbiologybusiness.industrySettore MED/34 - Medicina Fisica E RiabilitativaChronic painMultimodal therapyMiddle Agedmedicine.diseaseCombined Modality Therapysuperoxide dismutaseLipoic acidchemistrychronic neck painNeuropathic painbiology.proteinantioxidant supplementationFemaleChronic Painmedicine.symptombusinessOxidative stress
researchProduct

Vitiligo susceptibility and catalase gene (CAT) polymorphisms in sicilian population

2018

BACKGROUND Catalase gene (CAT) polymorphisms were analyzed as responsible for the deficiency of catalase enzyme activity and concomitant accumulation of excessive hydrogen peroxide in vitiligo patients. Catalase is a well-known oxidative stress regulator that could play an important role in the pathogenesis of vitiligo. This study was conducted to evaluate three CAT gene polymorphisms (-89A/T, 389C/T, 419C/T) and their association with vitiligo susceptibility in Sicilian population. METHODS Sixty out of 73 Sicilian patients with vitiligo were enrolled and submitted to CAT gene analysis. RESULTS Contrary to the Northern part of Europe but likewise to the Mediterranean area, the frequency of …

AdultMalevitiligoAdolescentGenotypePopulationDermatologyVitiligomedicine.disease_causePolymorphism Single NucleotidePathogenesis030207 dermatology & venereal diseases03 medical and health sciencesYoung Adult0302 clinical medicineCatalase GeneGenotypemedicineHumansGenetic Predisposition to Diseaseskin and connective tissue diseaseseducationSicily030203 arthritis & rheumatologyeducation.field_of_studyoxidative streintegumentary systembiologycatalaseHydrogen Peroxidemedicine.diseaseEnzyme assayCatalaseCase-Control StudiesImmunologybiology.proteinFemaleOxidative stress
researchProduct

Anti-Inflammatory Effects of Onions: Inhibition of Chemotaxis of Human Polymorphonuclear Leukocytes by Thiosulfinates and Cepaenes

1990

Seven different synthetic thiosulfinates, and cepaene- and/or thiosulfinate-rich onion extracts were found to inhibit in vitro the chemotaxis of human granulocytes induced by formyl-methionine-leucinephenylalanine in a dose-dependent manner and at a concentration range of 0.1–100 μ&lt;i&gt;M&lt;/i&gt;. Diphenylthiosulfinate showed the highest activity and was found to be more active than prednisolone. The anti-inflammatory properties of onion extracts are related, at least in part, to the inhibition of inflammatory cell influx by thiosulfinates and cepaenes.

AdultNeutrophilsmedicine.drug_classImmunologyInflammationIn Vitro TechniquesBiologyGranulocyteAnti-inflammatoryAlliumMicrobiologymedicineHumansImmunology and AllergyDisulfidesThiosulfinatePlant ExtractsLiliaceaeAnti-Inflammatory Agents Non-SteroidalChemotaxisGeneral Medicinebiology.organism_classificationIn vitroN-Formylmethionine Leucyl-PhenylalanineChemotaxis Leukocytemedicine.anatomical_structureBiochemistrySulfoxidesImmunologymedicine.symptomInternational Archives of Allergy and Immunology
researchProduct

Nitric oxide production and endothelium-dependent vasorelaxation ameliorated by N1-methylnicotinamide in human blood vessels.

2012

N 1 -methylnicotinamide (MNA + ) has until recently been thought to be a biologically inactive product of nicotinamide metabolism in the pyridine nucleotides pathway. However, the latest observations imply that MNA + may exert antithrombotic and anti-inflammatory effects through direct action on the endothelium. We examined both in vivo and in vitro whether the compound might induce vasorelaxation in human blood vessels through the improvement of nitric oxide (NO) bioavailability and a reduction of oxidative stress mediated by endothelial NO synthase (eNOS) function. MNA + treatment (100 mg/m 2 orally) in healthy normocholesterolemic and hypercholesterolemic subjects increased the l-argini…

AdultNiacinamidemedicine.medical_specialtyEndotheliumBrachial ArteryNitric Oxide Synthase Type IIIHypercholesterolemiachemistry.chemical_elementCalciumIn Vitro Techniquesmedicine.disease_causeNitric OxideNitric oxidechemistry.chemical_compoundN^{1}-methylnicotinamideDouble-Blind MethodEnosnitric oxideInternal medicineInternal MedicinemedicineHumansflow-mediated dilationCalcimycinCells Culturedendothelial nitric oxide synthaseoxidized low-density lipoproteinbiologyDose-Response Relationship DrugChemistrySuperoxidebiology.organism_classificationendothelial cellsAcetylcholineOxygenVasodilationOxidative Stressmedicine.anatomical_structureEndocrinologysuperoxideEndothelium VascularAcetylcholineOxidative stressmedicine.drugLipoproteinHypertension (Dallas, Tex. : 1979)
researchProduct